African Ancestry–Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent

Gene expression profiles in patients of African ancestry with triple-negative breast cancer indicate differences in normal breast tissue as well as in the tumor-associated immunologic profiles, supporting the potential differences in clinical outcomes between race groups.

[1]  K. Burnstein,et al.  Exploiting dependence of castration-resistant prostate cancer on the arginine vasopressin signaling axis by repurposing vaptans. , 2022, Molecular cancer research : MCR.

[2]  P. Danaher,et al.  Advances in mixed cell deconvolution enable quantification of cell types in spatial transcriptomic data , 2022, Nature Communications.

[3]  Melissa B. Davis,et al.  Oncologic Anthropology: An Interdisciplinary Approach to Understanding the Association Between Genetically Defined African Ancestry and Susceptibility for Triple Negative Breast Cancer , 2021, Current Breast Cancer Reports.

[4]  L. Newman,et al.  Breast cancer disparities in outcomes; unmasking biological determinants associated with racial and genetic diversity , 2021, Clinical & Experimental Metastasis.

[5]  S. Varambally,et al.  Comparative analysis of triple-negative breast cancer transcriptomics of Kenyan, African American and Caucasian Women , 2021, Translational oncology.

[6]  L. Conti,et al.  The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy , 2021, Frontiers in Oncology.

[7]  K. Owzar,et al.  Differential alternative RNA splicing and transcription events between tumors from African American and white patients in The Cancer Genome Atlas. , 2021, Genomics.

[8]  Melissa B. Davis,et al.  Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort , 2020, Scientific Reports.

[9]  L. Collin,et al.  Neighborhood-Level Redlining and Lending Bias Are Associated with Breast Cancer Mortality in a Large and Diverse Metropolitan Area , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[10]  L. Newman,et al.  Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival , 2020, BMC Medical Genomics.

[11]  Christopher D. Brown,et al.  Extended data: Impact of admixture and ancestry on eQTL analysis and GWAS colocalization in GTEx , 2020 .

[12]  J. Cortés,et al.  Atezolizumab in the treatment of metastatic triple-negative breast cancer , 2020, Expert opinion on biological therapy.

[13]  Jeffrey S. Damrauer,et al.  Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer , 2020, Cancer Cell.

[14]  Jason B. White,et al.  Identification of Distinct Heterogenic Subtypes and Molecular Signatures Associated with African Ancestry in Triple Negative Breast Cancer Using Quantified Genetic Ancestry Models in Admixed Race Populations , 2020, Cancers.

[15]  P. Fasching,et al.  Pembrolizumab for Early Triple-Negative Breast Cancer. , 2020, The New England journal of medicine.

[16]  Ahmedin Jemal,et al.  Breast cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[17]  R. Weiss,et al.  Targeting the Vasopressin Type 2 Receptor for Renal Cell Carcinoma Therapy , 2019, Oncogene.

[18]  S. Merajver,et al.  Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer Collaborative. , 2019, Annals of surgery.

[19]  S. Yeyeodu,et al.  Protective Innate Immune Variants in Racial/Ethnic Disparities of Breast and Prostate Cancer , 2019, Cancer Immunology Research.

[20]  Ash A. Alizadeh,et al.  Determining cell-type abundance and expression from bulk tissues with digital cytometry , 2019, Nature Biotechnology.

[21]  L. Newman,et al.  Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[22]  Paula Esther Moraga-Serrano.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016:A Systematic Analysis for the Global Burden of Disease Study , 2018 .

[23]  Adrian V. Lee,et al.  An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics , 2018, Cell.

[24]  Lara E Sucheston-Campbell,et al.  FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women? , 2017, Breast Cancer Research and Treatment.

[25]  W. Gradishar,et al.  Triple-Negative Breast Cancer: Current Practice and Future Directions. , 2017, Journal of oncology practice.

[26]  Melissa B. Davis,et al.  AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature , 2017, PloS one.

[27]  L. Newman,et al.  Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review , 2017, JAMA surgery.

[28]  A. Butte,et al.  xCell: digitally portraying the tissue cellular heterogeneity landscape , 2017, bioRxiv.

[29]  Ahmedin Jemal,et al.  Global Cancer in Women: Burden and Trends , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[30]  P. Chappuis,et al.  Opportunities for improving triple‐negative breast cancer outcomes: results of a population‐based study , 2017, Cancer medicine.

[31]  Lara E Sucheston-Campbell,et al.  Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer. , 2016, Human molecular genetics.

[32]  Zachary A. Szpiech,et al.  Genetic Ancestry and Natural Selection Drive Population Differences in Immune Responses to Pathogens , 2016, Cell.

[33]  Jeffrey T Leek,et al.  Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown , 2016, Nature Protocols.

[34]  Ernest Osei Bonsu,et al.  Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer , 2016, Annals of Surgical Oncology.

[35]  S. Merajver,et al.  Breast Cancer and African Ancestry: Lessons Learned at the 10-Year Anniversary of the Ghana-Michigan Research Partnership and International Breast Registry , 2016, Journal of global oncology.

[36]  Harold L. Moses,et al.  Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection , 2016, PloS one.

[37]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[38]  K. Ross,et al.  Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  E. Winer,et al.  Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  V. Seewaldt,et al.  Triple-negative breast cancer in African-American women: disparities versus biology , 2015, Nature Reviews Cancer.

[41]  David Reich,et al.  The Genetic Ancestry of African Americans, Latinos, and European Americans across the United States , 2015, American journal of human genetics.

[42]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[43]  L. Harris,et al.  Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy , 2013, PloS one.

[44]  D G Altman,et al.  Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study , 2013, British Journal of Cancer.

[45]  R. Wolff,et al.  Matrix Metalloproteinase Genes Are Associated with Breast Cancer Risk and Survival: The Breast Cancer Health Disparities Study , 2013, PloS one.

[46]  C. Tyler-Smith,et al.  Ethiopian genetic diversity reveals linguistic stratification and complex influences on the Ethiopian gene pool. , 2012, American journal of human genetics.

[47]  X. Chen,et al.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. , 2011, The Journal of clinical investigation.

[48]  David H. Alexander,et al.  Fast model-based estimation of ancestry in unrelated individuals. , 2009, Genome research.

[49]  R. Stephens,et al.  Differences in the Tumor Microenvironment between African-American and European-American Breast Cancer Patients , 2009, PloS one.

[50]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[51]  A. Rosenberg,et al.  Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients , 2007, Cancer.

[52]  R. Kittles,et al.  Race, Skin Color and Genetic Ancestry: Implications for Biomedical Research on Health Disparities , 2007 .

[53]  C. Perou,et al.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.

[54]  C. Péqueux,et al.  Provasopressin expression by breast cancer cells: implications for growth and novel treatment strategies , 2006, Breast Cancer Research and Treatment.

[55]  A. Rosenberg,et al.  Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: A single-institution compilation compared with the National Cancer Institute SEER database , 2005 .

[56]  R. Villems,et al.  Ethiopian mitochondrial DNA heritage: tracking gene flow across and around the gate of tears. , 2004, American journal of human genetics.

[57]  W. North.  Gene regulation of vasopressin and vasopressin receptors in cancer , 2000, Experimental physiology.

[58]  Russell Schwartz,et al.  Identification of novel mutations by exome sequencing in African American colorectal cancer patients , 2015, Cancer.

[59]  P. Underhill,et al.  Ethiopians and Khoisan share the deepest clades of the human Y-chromosome phylogeny. , 2002, American journal of human genetics.